Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Broustet

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Leukemia & Lymphoma|January 1, 1993
Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 casesJ Reiffers, M Montastruc, G Marit, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Infrequent sites of extramedullary relapse after allogeneic bone marrow transplantationF Viard, C Bilhou-Nabera, G Marit, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Treatment of acute myeloid leukemia in elderly patients: the influence of maintenance therapy (BGM 84 protocol)M Montastruc, J Reiffers, A M Stoppa, et al.
La Revue De Medecine Interne|July 1, 1992
[Lymphoproliferative syndrome with granular lymphocytes of CD8+ phenotype: a clonal pathology with a chronic course]J L Pellegrin, J P Merlio, P Cony-Makhoul, et al.
Bone Marrow Transplantation|May 1, 1996
High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemiaF X Mahon, C Fabères, M Montastruc, et al.
Leukemia|September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric studyG Marit, F Thiessard, C Faberes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
Leukemia|December 1, 1996
Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 studyJ Reiffers, A M Stoppa, M Attal, et al.
Leukemia|March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75J Reiffers, F Huguet, A M Stoppa, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Leukemia & Lymphoma|January 1, 1993
Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 casesJ Reiffers, M Montastruc, G Marit, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Infrequent sites of extramedullary relapse after allogeneic bone marrow transplantationF Viard, C Bilhou-Nabera, G Marit, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1990
Treatment of acute myeloid leukemia in elderly patients: the influence of maintenance therapy (BGM 84 protocol)M Montastruc, J Reiffers, A M Stoppa, et al.
La Revue De Medecine Interne|July 1, 1992
[Lymphoproliferative syndrome with granular lymphocytes of CD8+ phenotype: a clonal pathology with a chronic course]J L Pellegrin, J P Merlio, P Cony-Makhoul, et al.
Bone Marrow Transplantation|May 1, 1996
High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemiaF X Mahon, C Fabères, M Montastruc, et al.
Leukemia|September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric studyG Marit, F Thiessard, C Faberes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.
Leukemia|September 26, 1997
Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic LeukemiaA Delannoy, C Sebban, P Cony-Makhoul, et al.
Leukemia|December 1, 1996
Allogeneic vs autologous stem cell transplantation vs chemotherapy in patients with acute myeloid leukemia in first remission: the BGMT 87 studyJ Reiffers, A M Stoppa, M Attal, et al.
Leukemia|March 1, 1996
A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for acute myelogenous leukemia of the age group 55 to 75J Reiffers, F Huguet, A M Stoppa, et al.
Pageof 14